This inventor holds 3 USPTO granted patents. Top assignee: The University of Texas System. Active years: 1998-2003.
Location History:
- Cooperstown, NY (US) (2001)
- Galveston, TX (US) (1998 - 2003)
Company Filing History:
Years Active: 1998-2003
Title: Innovations by Inventor Allan Green
Introduction
Allan Green is a notable inventor based in Galveston, TX (US). He has made significant contributions to the field of medicine, particularly in cancer treatment. With a total of 3 patents to his name, his work focuses on the use of specific compounds to address critical health issues.
Latest Patents
One of Allan Green's latest patents involves the use of Troglitazone and related thiazolidinedione compounds for the treatment of cancer. This invention is based on the discovery that Troglitazone inhibits steroidogenesis in granulosa cell cultures. The activity of Troglitazone is believed to stem from its ability to act as a ligand for the orphan steroid receptor peroxisome proliferator-activated receptor gamma (PPARγ). This mechanism allows Troglitazone and its derivatives to potentially prevent excessive uterine bleeding and block transcription in rapidly proliferating cancer cells that express PPARγ, leading to a loss of cell viability.
Career Highlights
Allan Green is affiliated with the University of Texas System, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on cancer treatment and women's health.
Collaborations
Allan collaborates with various professionals in his field, including his coworker Randall J Urban. Their combined expertise contributes to the development of innovative solutions in medical research.
Conclusion
Allan Green's contributions to the field of cancer treatment through his innovative use of Troglitazone compounds highlight the importance of research and development in medicine. His work exemplifies the potential of scientific innovation to improve health outcomes.